SHR-1701 in Metastatic or Locally Advanced Solid Tumors

Condition:   Solid Tumor Intervention:   Drug: SHR-1701 Sponsor:   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting

Source: ClinicalTrials.gov - October 18, 2018 Category: Research Source Type: clinical trials